Neuro-Degenerative
ALS
ALS moves quickly. The intelligence surrounding it should move with equal purpose.

Why these diseases
Helixera exists to ensure no one misses a meaningful advancement in the disease that matters to them. We chose our first ten diseases deliberately: each combines profound human need with a research landscape that is active, fragmented, and difficult to follow continuously.
10
approved diseases
3
connected focus areas
0
medical advice
1
continuous intelligence mission

High-impact disease landscapes where families are balancing urgent questions with rapidly expanding research.
Neuro-Degenerative
ALS moves quickly. The intelligence surrounding it should move with equal purpose.
Neuro-Degenerative
A vast research field should not leave families searching alone.
Neuro-Degenerative
Progress spans movement, biology, devices, care, and a growing range of therapeutic ideas.

Closely connected communities where every credible trial, designation, and scientific step can matter.
Orphan/Rare
A closely connected community deserves a continuous view of every credible step forward.
Orphan/Rare
Rapid therapeutic change makes long-term, source-linked continuity essential.
Orphan/Rare
Transformative progress still arrives unevenly, one genotype and program at a time.

Fast-moving cancer research where trial setting, biomarkers, timing, and evidence quality shape the meaning of progress.
Precision Oncology
In an unforgiving disease, experimental signals need context, precision, and restraint.
Precision Oncology
Small advances can carry outsized meaning in a landscape that demands speed and rigor.
Precision Oncology
Fast-moving treatment science demands an equally connected view of evidence and access.
Precision Oncology
Aggressive disease biology makes timely, source-grounded monitoring especially important.
Helixera disease pages organize source-linked intelligence and do not provide diagnosis, treatment recommendations, medical advice, or emergency guidance.